OR WAIT null SECS
September 19, 2023
Experts discussed how to transform companies into learning organizations at the 2023 PDA/FDA Joint Regulatory Conference.
Iopofosine provides targeted delivery of idodine-131 directly to cancer cells.
September 18, 2023
The EMA’s Committee for Medicinal Products for Human Use has given a positive opinion on Sandoz’ biosimilar trastuzumab for breast and gastric cancer.
The draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.
September 14, 2023
Colorcon provides customers with Opadry complete film coating systems, which intends to help reduce complexity with delivering high-quality products and ingredients.
September 08, 2023
The new policy will require trading partners to supply, accept, and manage all documentation of product and ownership of prescription drugs electronically.
September 06, 2023
Advanced analytical tools generate more data in today’s labs than ever before.
September 03, 2023
Excipients should be treated equally when it comes to quality management, risk assessment, and testing.
FDA is anticipating how AI may advance manufacturing and improve supply chain security.
Recent research and perspectives shed light on an opportunity to better connect risk and knowledge through improved integration of systems.